Discontinuation report INTEGRILIN

Last updated on 2022-11-18 History
Report ID 155794
Drug Identification Number 02240352
Brand name INTEGRILIN
Common or Proper name eptifibatide injection
Company Name MERCK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20 mg/10 mL bolus vial - Fiole de 20 mg/10 mL pour bolus
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-10-18
Actual discontinuation date 2022-10-17
Remaining supply date 2022-10-18
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-03-01 English Compare
v2 2022-03-01 French Compare
v3 2022-05-10 English Compare
v4 2022-05-10 French Compare
v5 2022-09-26 English Compare
v6 2022-09-26 French Compare
v7 2022-09-26 English Compare
v8 2022-09-26 French Compare
v9 2022-10-14 English Compare
v10 2022-10-14 French Compare
v11 2022-10-18 English Compare
v12 2022-10-18 French Compare
v13 2022-11-18 French Compare

Showing 1 to 13 of 13